Phase II Trial of Ponatinib in Patients with Metastatic Gastrointestinal Stromal Tumor following Failure or Intolerance of Prior Therapy with Imatinib (POETIG Trial)

Falkenhorst, Johanna; Ivanyi, Philipp; Schulz, Tom; Hamacher, Rainer; Kasper, Bernd; Hohenberger, Peter; Deinzer, Christoph K. W.; Pink, Daniel; Fletcher, Benjamin S.; Haller, Valerie; Optaczy, Yasmin; Grunewald, Susanne; Rauh, Daniel; Marino-Enriquez, Adrian; Muhlenberg, Thomas; Reichardt, Peter; Bauer, Sebastian

Phase II Trial of Ponatinib in Patients with Metastatic Gastrointestinal Stromal Tumor following Failure or Intolerance of Prior Therapy with Imatinib (POETIG Trial)

Autor(en):

Falkenhorst, Johanna; Ivanyi, Philipp; Schulz, Tom; Hamacher, Rainer; Kasper, Bernd; Hohenberger, Peter; Deinzer, Christoph K. W.; Pink, Daniel; Fletcher, Benjamin S.; Haller, Valerie; Optaczy, Yasmin; Grunewald, Susanne; Rauh, Daniel; Marino-Enriquez, Adrian; Muhlenberg, Thomas; Reichardt, Peter; Bauer, Sebastian

Tübinger Autor(en):

Deinzer, Christoph K. W.

Erschienen in:

Clinical Cancer Research (2025), Bd. 31, H. 19, S. 4059-4069

Verlagsangabe:

Philadelphia : Amer Assoc Cancer Research

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1158/1078-0432.CCR-25-0222

ISSN:

1078-0432